Recommendation ID
IPG453/1
Question
Further research on prostate artery embolisation for benign prostatic hyperplasiain the form of randomised trials or cohort studies (for example, using an appropriate register) should clearly document patient selection criteria and all complications, specifically including disturbance of sexual function. Efficacy outcomes should include measures of urinary function, symptoms and quality of life. Information about longer-term outcomes, including the need for further treatment, would be valuable.
Any explanatory notes
(if applicable)
Current evidence on the safety and efficacy of prostate artery embolisation for benign prostatic hyperplasia is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.

Source guidance details

Comes from guidance
Prostate artery embolisation for benign prostatic hyperplasia
Number
IPG453
Date issued
April 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 25/04/2013